Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


09.09.2019

1 Aging (Albany NY)
1 Ann Vasc Surg
1 BMJ Open
1 Cancer Med
1 Cancer Prev Res (Phila)
1 Cancers (Basel)
2 Cent European J Urol
1 Eur Rev Med Pharmacol Sci
2 Eur Urol
1 Front Oncol
1 Hinyokika Kiyo
1 Life Sci
1 Med Sci Monit
2 Medicine (Baltimore)
1 Methods Mol Biol
1 Mol Cancer
1 Nihon Shokakibyo Gakkai Zasshi
1 Prog Urol
1 Surg Technol Int
3 Urol Oncol
1 Urology
1 Vet Clin North Am Small Anim Pract
1 Virchows Arch
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aging (Albany NY)

  1. LIAN P, Wang Q, Zhao Y, Chen C, et al
    An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer.
    Aging (Albany NY). 2019;11.
    PubMed     Text format     Abstract available


    Ann Vasc Surg

  2. BERCHIOLLI R, Mocellin DM, Marconi M, Tomei F, et al
    Ruptured Mycotic Aneurysm After Intravesical Instillation for Bladder Tumor.
    Ann Vasc Surg. 2019;59:310.
    PubMed     Text format     Abstract available


    BMJ Open

  3. TANDOGDU Z, Lewis R, Duncan A, Penegar S, et al
    Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectiveness.
    BMJ Open. 2019;9:e022268.
    PubMed     Text format     Abstract available


    Cancer Med

  4. KARIM S, Mackillop WJ, Brennan K, Peng Y, et al
    Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer.
    Cancer Med. 2019 Aug 31. doi: 10.1002/cam4.2449.
    PubMed     Text format     Abstract available


    Cancer Prev Res (Phila)


  5. Expression of Concern: Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer.
    Cancer Prev Res (Phila). 2019 Sep 3. pii: 1940-6207.CAPR-19-0406.
    PubMed     Text format    


    Cancers (Basel)

  6. MATARAZZO S, Melocchi L, Rezzola S, Grillo E, et al
    Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression.
    Cancers (Basel). 2019;11.
    PubMed     Text format     Abstract available


    Cent European J Urol

  7. GRONOSTAJ K, Czech AK, Fronczek J, Wiatr T, et al
    Implementation of neoadjuvant chemotherapy in muscle invasive bladder cancer treatment in Poland: a single institution retrospective study.
    Cent European J Urol. 2019;72:100-105.
    PubMed     Text format     Abstract available

  8. BIANCHI FM, Romagnoli D, D'Agostino D, Corsi P, et al
    Is robotic approach useful to palliate advanced bladder cancer? A monocentric single surgeon experience.
    Cent European J Urol. 2019;72:113-120.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  9. DAI L, Chai CM, Shen TY, Tian Y, et al
    LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.
    Eur Rev Med Pharmacol Sci. 2019;23:6858-6867.
    PubMed     Text format     Abstract available


    Eur Urol

  10. VARMA M, Delahunt B, Kwast TV
    Reply to Eva Comperat, Mahul Amin, Victor Reuter's Editorial Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol. In press. htt
    Eur Urol. 2019 Aug 29. pii: S0302-2838(19)30676.
    PubMed     Text format    

  11. YANG A, Cannataro VL, Townsend JP
    Re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer. Eur Urol 2019;76:9-13.
    Eur Urol. 2019 Aug 29. pii: S0302-2838(19)30662.
    PubMed     Text format    


    Front Oncol

  12. WANG X, Ni X, Tang G
    Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis.
    Front Oncol. 2019;9:757.
    PubMed     Text format     Abstract available


    Hinyokika Kiyo

  13. SAGEHASHI R, Ichimura Y, Iinuma M
    [Primary Adenocarcinoma of the Bladder at the Vesicocutaneostomy Site Occuring 30 Years after the Operation].
    Hinyokika Kiyo. 2019;65:167-170.
    PubMed     Text format     Abstract available


    Life Sci

  14. LEI Y, Yang L, Hongwei J, Hongyuan Y, et al
    TIS111D can affect bladder cancer cells by regulating epithelial-mesenchymal transition.
    Life Sci. 2019 Sep 3:116832. doi: 10.1016/j.lfs.2019.116832.
    PubMed     Text format     Abstract available


    Med Sci Monit

  15. NIU L, Gao Z, Cui Y, Yang X, et al
    Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer.
    Med Sci Monit. 2019;25:6660-6668.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  16. JIAN X, Shen M, Liao G
    Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study.
    Medicine (Baltimore). 2019;98:e16873.
    PubMed     Text format     Abstract available

  17. ZHU F, Zhang Y, Shi L, Wu CL, et al
    Gene mutation detection of urinary sediment cells for NMIBC early diagnose and prediction of NMIBC relapse after surgery.
    Medicine (Baltimore). 2019;98:e16451.
    PubMed     Text format     Abstract available


    Methods Mol Biol

  18. RELPH K, Annels N, Smith C, Kostalas M, et al
    Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus: Using a Bladder Tumor Precision-Cut Slice Model System to Assess Viral Efficacy.
    Methods Mol Biol. 2020;2058:249-259.
    PubMed     Text format     Abstract available


    Mol Cancer

  19. BI J, Liu H, Dong W, Xie W, et al
    Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
    Mol Cancer. 2019;18:133.
    PubMed     Text format     Abstract available


    Nihon Shokakibyo Gakkai Zasshi

  20. HIROSE Y, Kinoshita A, Ishii A, Ishimoto U, et al
    [Successful treatment of unresectable advanced gastric cancer with bladder metastasis using mFOLFOX6:a case report].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:676-684.
    PubMed     Text format     Abstract available


    Prog Urol

  21. NEUZILLET Y, Geiss R, Caillet P, Paillaud E, et al
    [Epidemiological, pathological and prognostic characteristics of bladder cancer in elderly patients].
    Prog Urol. 2019 Aug 27. pii: S1166-7087(19)30456.
    PubMed     Text format     Abstract available


    Surg Technol Int

  22. ROMAGNOLI D, Bianchi FM, Corsi P, D'Agostino D, et al
    Robot-Assisted Radical Cystectomy with Intracorporeal Orthotopic Ileal Neobladder: A Safe Strategy in Elderly Patients? Results of Propensity Score Matching in a Single High-Volume Center.
    Surg Technol Int. 2019;34:302-309.
    PubMed     Text format     Abstract available


    Urol Oncol

  23. AUDENET F, Sfakianos JP, Waingankar N, Ruel NH, et al
    A delay >/=8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging.
    Urol Oncol. 2019;37:116-122.
    PubMed     Text format     Abstract available

  24. RICHTERS A, Dickman PW, Witjes JA, Boormans JL, et al
    Bladder cancer survival: Women only fare worse in the first two years after diagnosis.
    Urol Oncol. 2019 Aug 31. pii: S1078-1439(19)30319.
    PubMed     Text format     Abstract available

  25. DANIELS MJ, Barry E, Milbar N, Schoenberg M, et al
    An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle-invasive bladder cancer.
    Urol Oncol. 2019 Aug 28. pii: S1078-1439(19)30299.
    PubMed     Text format     Abstract available


    Urology

  26. AJAJ R, Berlin A, Klaassen Z, Chandrasekar T, et al
    Age differences in patient-reported psychological and physical distress symptoms in bladder cancer patients - A Cross Sectional Study.
    Urology. 2019 Sep 2. pii: S0090-4295(19)30786.
    PubMed     Text format     Abstract available


    Vet Clin North Am Small Anim Pract

  27. WILEY C, Wise CF, Breen M
    Novel Noninvasive Diagnostics.
    Vet Clin North Am Small Anim Pract. 2019;49:781-791.
    PubMed     Text format     Abstract available


    Virchows Arch

  28. RODRIGUEZ PENA MDC, Chaux A, Eich ML, Tregnago AC, et al
    Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
    Virchows Arch. 2019;475:349-356.
    PubMed     Text format     Abstract available


    World J Urol

  29. DELCOURT C, Gemival P, Nouhaud FX, Gobet F, et al
    Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC).
    World J Urol. 2019 Sep 5. pii: 10.1007/s00345-019-02896.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: